We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$323B
AUM Growth
+$11.5B
Cap. Flow
+$13.1B
Cap. Flow %
4.05%
Top 10 Hldgs %
14.39%
Holding
7,731
New
673
Increased
3,224
Reduced
3,031
Closed
497

Sector Composition

Rank Sector Weight
1 Financials 8.41%
2 Healthcare 8.04%
3 Technology 7.66%
4 Energy 6.94%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARIA
2676
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$6.62M ﹤0.01%
800,478
+299,575
+60% +$2.65M
BHE icon
2677
Benchmark Electronics
BHE
$2.91B
$6.59M ﹤0.01%
302,531
+16,654
+6% +$394K
EA icon
2678
CALL
Electronic Arts
EA
$53B
$6.58M ﹤0.01%
99,000
+40,100
+68% +$2.47M
BTU
2679
PUT
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$6.58M ﹤0.01%
200,233
+141,233
+239% +$8.26M
FRME icon
2680
First Merchants
FRME
$2.69B
$6.57M ﹤0.01%
265,991
+145,103
+120% +$3.42M
RSPD icon
2681
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$316M
$6.57M ﹤0.01%
218,001
+66,801
+44% +$2.03M
EWL icon
2682
iShares MSCI Switzerland ETF
EWL
$2.19B
$6.57M ﹤0.01%
200,546
-27,198
-12% -$946K
BG icon
2683
CALL
Bunge Global
BG
$20.2B
$6.56M ﹤0.01%
74,700
+27,300
+58% +$2.43M
VRTX icon
2684
PUT
Vertex Pharmaceuticals
VRTX
$120B
$6.56M ﹤0.01%
53,100
+22,600
+74% +$2.85M
XME icon
2685
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$3.86B
$6.56M ﹤0.01%
269,500
+68,200
+34% +$1.86M
DG icon
2686
PUT
Dollar General
DG
$28.1B
$6.55M ﹤0.01%
84,300
-32,500
-28% -$2.45M
UTHR icon
2687
CALL
United Therapeutics
UTHR
$25.8B
$6.54M ﹤0.01%
37,600
+20,900
+125% +$3.76M
CRL icon
2688
Charles River Laboratories
CRL
$11.2B
$6.54M ﹤0.01%
92,974
-6,330
-6% -$468K
MDU icon
2689
MDU Resources
MDU
$4.18B
$6.54M ﹤0.01%
880,701
-54,607
-6% -$439K
JWN
2690
CALL
DELISTED
Nordstrom
JWN
$6.52M ﹤0.01%
87,500
+43,500
+99% +$3.31M
ARIA
2691
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$6.52M ﹤0.01%
788,200
-268,400
-25% -$2.37M
UPBD icon
2692
Upbound Group
UPBD
$1.14B
$6.52M ﹤0.01%
229,861
+59,628
+35% +$1.79M
CBI
2693
CALL
DELISTED
Chicago Bridge & Iron Nv
CBI
$6.51M ﹤0.01%
130,100
-31,000
-19% -$1.61M
THOR
2694
CALL
DELISTED
THORATEC CORPORATION
THOR
$6.51M ﹤0.01%
+146,000
New +$6.39M
ATW
2695
DELISTED
Atwood Oceanics
ATW
$6.5M ﹤0.01%
245,906
+91,918
+60% +$2.82M
CVSA
2696
Covista Inc
CVSA
$4.25B
$6.5M ﹤0.01%
216,842
-10,360
-5% -$342K
UEIC icon
2697
Universal Electronics
UEIC
$58.1M
$6.49M ﹤0.01%
130,280
+28,271
+28% +$1.52M
BSX icon
2698
CALL
Boston Scientific
BSX
$67.3B
$6.47M ﹤0.01%
365,800
+133,000
+57% +$2.38M
TNA icon
2699
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.29B
$6.47M ﹤0.01%
144,714
+101,534
+235% +$4.58M
POLY
2700
DELISTED
Plantronics, Inc.
POLY
$6.45M ﹤0.01%
114,505
+18,660
+19% +$1.04M

Similar funds

Goldman Sachs's Q2 2015 Portfolio in Review

As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.

  • Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
  • Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
  • Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
  • Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
  • Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
  • Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.